Press Releases

and/or
565 News Releases found
MSK-Impact
AACR Virtual Annual Meeting 2020 II: MSK Research Shows that Young Adults with Early-Onset Cancer Are at High Risk of Harboring Inherited Genetic Mutations

A study from Memorial Sloan Kettering found that young patients ages 18 to 39 with early-onset cancer have an especially high risk of harboring inherited genetic (germline) mutations.
MSK Physician-Scientists Recognized with Top Honors by AACR, ASCO, and ASH Organizations

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and honors, given by the American Association for Cancer Research (AACR), the American Society of Clinical Oncology (ASCO), and the American Society of Hematology (ASH) organizations.
Visible Ink
MSK’s Visible Ink Writing Program Presents “On Cancer and Coronavirus,” Performed by Stars of Broadway, Film and TV

On Thursday, June 18th at 6:00 p.m. E.T. with an encore at 9:00 p.m., MSK will stream a special performance highlighting poignant and humorous perspectives On Cancer and Coronavirus, featuring works from its writing program, Visible Ink.
A MSK Kids patient with his MSK Kids Nurse Practitioner
MSK KIDS Ranked One of the Best Children’s Hospitals Nationally in Pediatric Cancer Care by U.S. News & World Report

MSK Kids, the pediatric oncology program at Memorial Sloan Kettering Cancer Center (MSK) has been named one of the best children’s hospitals nationally, according to U.S. News & World Report in its annual “Best Children’s Hospitals” list. MSK Kids is ranked 13th in the nation. MSK Kids has been ranked by U.S. News & World Report for the past 12 years.
MSK Awards & Appointments

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
Charles L. Sawyers, MD
Memorial Sloan Kettering’s Charles L. Sawyers, MD, Named American Association for Cancer Research Academy President-Elect

The Fellows of the American Association for Cancer Research (AACR) have elected Charles L. Sawyers, MD, chair of the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center (MSK), as their President-Elect for 2020–2021.
MSK Bergen
Memorial Sloan Kettering – Hackensack Meridian Health Partnership Announces Funding for Inaugural Immunology Research Collaboration Projects

The Memorial Sloan Kettering – Hackensack Meridian Health Partnership has formed an Immunology Research Collaboration to support innovative investigations into the power of the immune system to fight cancer.
Blue flag with Memorial Sloan Kettering logo
A Letter to the MSK Community

Read a letter from Memorial Sloan Kettering's leadership team about our commitment to our community in response to acts of racism and discrimination.
Paul K. Paik, MD, Clinical Director, Thoracic Oncology Service
ASCO 2020: Targeted Treatment Shows Promise in Non-Small Cell Lung Cancer

Researchers at MSK published updated data today in the New England Journal of Medicine from the ongoing, single-arm Phase II VISION study evaluating tepotinib as a single agent in patients with advanced non-small cell lung cancer (NSCLC) with MET exon 14 (METex14) skipping alterations.
MSK radiologist reviews a scan
MSK: Cancer Isn’t Sheltering in Place

As the height of the COVID-19 outbreak in New York City and the Tri-State area begins to subside, oncologists at Memorial Sloan Kettering Cancer Center (MSK) are urging patients to schedule cancer screenings and treatments now.